Methods for treating B-cell malignancies using a TACI-Ig fusion molecule
US7842292B2 · kind B2 · utility
1Cited by
48References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 9, 2006 |
| Grant date | Nov 30, 2010 |
| Priority date | — |
| Expiry date | Aug 9, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods and compositions for treatment of B-cell malignancies, including non-Hodgkin's lymphoma, comprising administering to a patient in need of the treatment a TACI-Ig fusion molecule in amount sufficient to suppress proliferation-inducing functions of BlyS and APRIL.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.